Previous 10 | Next 10 |
home / stock / tbpmf / tbpmf news
DIN submission to be completed in Q4 2020 OTTAWA, ON / ACCESSWIRE / October 7, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") ( TSX:TBP ) ( OTCQB:TBPMF ), a leader in cannabinoid-derived drug discovery and development, is pleased to provide an update on its commercial strat...
NEW YORK, NY / ACCESSWIRE / October 6, 2020 / Alpha Bronze, LLC ("Alpha Bronze"), is pleased to announce that Tetra Bio-Pharma ( TSX:TBP ) ( OTCQB:TBPMF ), ("Tetra Bio-Pharma" or the "Company"), a leader in cannabinoid-derived drug discovery and development, will be presenting at Alpha Bronz...
Tetra Bio-Pharma ([[TBPMF]] -0.7%) entered into a definitive agreement with U.S. strategic partner to acquire the Canadian exclusive rights for Dronabinol Soft Gel capsules for two undisclosed milestones.Tetra will be submitting a new drug submission application in FQ4 to obtai...
Tetra is ready to submit its first New Drug Submission application to commercialize a THC-based prescription drug in Canada. Will facilitate the introduction of CAUMZ TM Significantly reinforce our core business Allows Tetra to establish a revenue stream OTTAWA...
Tetra Bio-Pharma ( OTCQB:TBPMF ) adds Ms. Dale Weil and Dr. Brent Norton to the Company's Board and appointed Dr. Graham Wood, Ph.D. as COO . More news on: Tetra Bio-Pharma Inc., Healthcare stocks news, Read more ...
OTTAWA, ON / ACCESSWIRE / September 17, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") ( TSX:TBP.TO ) ( OTCQB:TBPMF ), a leader in cannabinoid-derived drug discovery and development, is pleased to announce that Ms. Dale Weil and Dr. Brent Norton have been appointed to the Company'...
OTTAWA, ON / ACCESSWIRE / September 11, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") ( TSX:TBP ) ( OTCQB:TBPMF ), a leader in cannabinoid-derived drug discovery and development, is pleased to announce the appointment of Jean-Francois Boily, CPA, CA, as Chief Financial Officer an...
Brings over 20 years of commercial and medical expertise in the pharmaceutical industry and the cannabis space OTTAWA, ON / ACCESSWIRE / September 4, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") ( TSX:TBP ) ( OTCQB:TBPMF ), a leader in cannabinoid-derived drug discovery and...
Pharmaceutical GMP grade QIXLEEF™ shipped OTTAWA, ON / ACCESSWIRE / September 2, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") ( TSX:TBP ) ( OTCQB:TBPMF ), a leader in cannabinoid-derived drug discovery and development, is pleased to announce that it has initiated the...
Tetra defines CBD Metabolism in Humans Following QIXLEEF ™ Inhalation Data from metabolite study provides explanation for inhalation as a safe route of administration OTTAWA, ON / ACCESSWIRE / August 27, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") ( TSX:...
News, Short Squeeze, Breakout and More Instantly...
Tetra Bio-Pharma Inc Company Name:
TBPMF Stock Symbol:
OTCMKTS Market:
Tetra Bio-Pharma Inc Website:
(TheNewswire) Montreal – TheNewswire - August 1, 2023 – Tetra Bio-Pharma Inc. (“ Tetra ” or the “ Company ”) ( TSX:TBP ) ( OTC:TBPMF ) (FRA:JAM1) a leader in cannabinoid-derived drug discovery and development announced that...
(TheNewswire) MONTREAL, QUEBEC – TheNewswire – May 11, 2023 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP) (OTC:TBPMF) (FRA:JAM1), a leader in cannabinoid-derived drug discovery and development, today announced it has cancelled its New Drug Subm...
(TheNewswire) Montreal, QC - TheNewswire - March 10, 2023 - Tetra Bio-Pharma Inc. (" Tetra " or the " Company ") (TSX:TBP) (OTC:TBPMF) (FRA:JAM1) , a leader in cannabinoid-derived drug discovery and development is pleased to announce Health Canada h...